Category: eClinical Systems
Data capture, trial management, document, supply, lab, and patient-reported systems each hold a slice of the trial, and keeping them reconciled consumes data-management time.
A single trial runs on a stack of systems — data capture, trial management, document management, randomization and supply, central labs, patient-reported outcomes — each with its own copy of overlapping facts. Keeping those copies consistent is a standing reconciliation burden: mismatched visit dates, subjects present in one system and missing in another, lab results that never landed. AI-assisted reconciliation continuously compares data across sources and flags the discrepancies, so data managers work a prioritized exception list instead of eyeballing listings.
Cross-system reconciliation tools connect to the trial's data sources and continuously compare the facts they share: subject identifiers and status, visit dates, sample and result pairs, dosing and dispensation records. Matching logic tolerates the format differences that make naive comparison useless — different date conventions, identifier schemes, and naming — and surfaces genuine discrepancies as an exception queue with the evidence attached. Some tools add anomaly detection on top, flagging patterns that are internally consistent but unusual enough to warrant a look. What the tooling does not replace is the resolution: deciding which system is right, issuing the query, and correcting the record remain data-management work, and the underlying integration architecture is still an engineering and vendor-selection question. The practical gain is that expert time goes to resolving discrepancies rather than finding them, and problems surface while the site visit is recent enough to fix them cleanly.
Connector coverage comes first and is unglamorous: the tool has to read from the specific systems and versions your trials actually use, and a missing connector means a manual feed that recreates the problem. Then probe discrepancy precision on real data — a tool that floods the queue with false mismatches from format noise trains the team to ignore it, which is worse than the original listings. Ask for a trial run on one of your own studies and measure the signal-to-noise of what it flags. Because flagged discrepancies drive queries and corrections in regulated data, examine the audit trail: what was compared, what was flagged, who resolved it and how. And check the boundary honestly — reconciliation tooling makes the seams between systems manageable; it does not merge the systems, and it should not be sold or bought as an integration strategy.
A contained pilot picks one active study and its two highest-friction sources — commonly data capture and central lab — and runs the tool's comparisons alongside the existing manual reconciliation listings for a few cycles. Comparing the exception queue against what the team found manually measures both coverage and noise on ground truth. Teams that see clean signal typically extend to more source pairs on the same study before rolling across the portfolio.
It continuously compares the overlapping facts across your trial systems — subjects, visits, samples, dosing — and flags genuine discrepancies as a prioritized exception queue with evidence attached. Data managers still decide which system is right and issue the corrections; the tool removes the finding, not the fixing.
No. It makes the seams between systems manageable by catching inconsistencies early, but the systems remain separate, and integration architecture remains an engineering decision. Treat reconciliation as a control on top of your current stack, not as a substitute for connecting it properly.
Noise. If format differences and benign variations flood the exception queue with false mismatches, the team learns to ignore it and the tool becomes shelfware. Test precision on your own data before committing — the flag rate has to be dominated by discrepancies worth a query.
Which of our specific systems and versions do you connect to today, what does the exception queue look like on a real study of ours, what is the false-positive rate your current customers see, how are comparisons and resolutions audit-trailed, and what happens when a source system changes its export format mid-study.
Syntegra partnered with Datavant to connect its synthetic data engine with Datavant's de-identification and record-linking network, enabling privacy-preserving exchange of synthetic versions of linked real-world health datasets across the healthcare ecosystem.
Vendor: Syntegra · press release (Syntegra (GlobeNewswire)) · 2022-12-15 — Partner: Datavant
Abridge was named the first member of Epic's 'Pals' partnership program, integrating its generative-AI medical conversation summaries directly into Epic EHR workflows so health systems can adopt ambient documentation inside the tools clinicians already use.
Vendor: Abridge · press release (Abridge) · 2023-08-16 — Partner: Epic
Saama's AI-driven clinical analytics supported Pfizer's review of clinical trial data during its COVID-19 vaccine program; the companies subsequently expanded their relationship across Pfizer's broader R&D data operations.
Vendor: Saama Technologies · press release (Saama (Business Wire)) · 2024-02-12 — Partner: Pfizer
Kaiser Permanente rolled out Abridge's ambient AI clinical documentation technology across its integrated health system — 40 hospitals and more than 600 medical offices — letting clinicians generate draft visit notes from patient conversations instead of typing during encounters.
Vendor: Abridge · press release (Kaiser Permanente) · 2024-08-14 — Partner: Kaiser Permanente
A quality-improvement survey at the University of Kansas Medical Center, published in JAMIA Open, reported that clinicians using Abridge's ambient AI documentation self-reported lower perceived work burden and burnout and higher job satisfaction after implementation. Vendor-affiliated authors participated in the study.
Vendor: Abridge · peer reviewed (JAMIA Open (Oxford University Press)) · 2025-02-21